Formulation, manufacturing, quality and market-readiness guidance for brand owners.
A compliance-focused review of KPV peptide anti inflammation strips, ingredient status, drug-versus-supplement boundaries, claims and market-entry evidence.
Read technical guide →
A compliance-focused review of DSIP peptide sleep strips, ingredient status, drug-versus-supplement boundaries, claims and market-entry evidence.
Read technical guide →A compliance-focused review of MOTS-c peptide oral strips, ingredient status, drug-versus-supplement boundaries, claims and market-entry evidence.
Read technical guide →
A responsible development guide to NAD+ oral peptide strips, covering dose feasibility, stability, sensory design, testing and market eligibility.
Read technical guide →
A compliance-focused review of PT-141 oral peptide strips, ingredient status, drug-versus-supplement boundaries, claims and market-entry evidence.
Read technical guide →
A compliance-focused review of Thymosin Alpha 1 oral strips, ingredient status, drug-versus-supplement boundaries, claims and market-entry evidence.
Read technical guide →
A compliance-focused review of CJC 1295 Ipamorelin oral strips, ingredient status, drug-versus-supplement boundaries, claims and market-entry evidence.
Read technical guide →
A compliance-focused review of BPC-157 oral peptide strips, ingredient status, drug-versus-supplement boundaries, claims and market-entry evidence.
Read technical guide →
A responsible development guide to glutathione peptide oral strips, covering dose feasibility, stability, sensory design, testing and market eligibility.
Read technical guide →Product packaging images are AI-generated design concepts for OEM discussion, not photographs of finished commercial stock. Final artwork, formula, pack count and market eligibility are confirmed for each project.
